Treatment Patterns and Outcomes of Patients With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer in Tanzania
Trastuzumab significantly improves OS in resource-limited settings, particularly in patients with hormone receptor-negative HER2+BC. There are disparities in access to trastuzumab in Tanzania.
Authors
- Mamsau Ngoma (ORCID: https://orcid.org/0000-0003-1382-8037)
- Queen Tarimo
- Emmanuel Lugina (ORCID: https://orcid.org/0000-0002-9083-4302)
- Lemi Ndugumbi Zinga
- Kelvin Mbelekwa
Institutions
- Muhimbili University of Health and Allied Sciences (TZ)
- Ocean Road Cancer Institute (TZ)
Publication Details
- Journal
- JCO Global Oncology
- Published
- 2025-08-01
- DOI
- https://doi.org/10.1200/go-24-00612
- Citations
- 1
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 1.52